Day: September 23, 2020

VANCOUVER, Washington, Sept. 22, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the Phase 2 study of leronlimab for mild-to-moderate COVID-19 patients has been selected for an oral presentation at the upcoming Special isirv-Antiviral Group Conference on ‘Therapeutics for COVID-19.’ The Conference is sponsored by the International Society for Influenza and other Respiratory Virus Diseases, an independent and international scientific professional society promoting the prevention, detection, treatment, and control of influenza and other respiratory virus disease.Abstract Title: “A Phase 2 Study of Leronlimab for Mild to Moderate Coronavirus...

 Aktian rahastot nousevat kärkeen, kun verrataan eri rahastoyhtiöiden rahastojen saamia Morningstar-luokituksia Suomessa. Aktian rahastojen keskiarvo elokuussa 2020 oli 4,20 tähteä, kun seuraavaksi parhaan kilpailijan keskiarvo oli 3,77. Morningstarin luokitusten perusteella tehdyssä vertailussa on huomioitu kunkin rahaston eniten tähtiä saanut rahasto-osuuslaji.”Olemme todella iloisia siitä, että tuloksekas ja pitkäjänteinen työmme näkyy selvästi myös tässä vertailussa. Morningstarin luokituksissa voi menestyä vain, jos on tuottanut erityisen hyviä tuloksia pitkällä aikavälillä”, sanoo Aktian sijoitustoiminnasta vastaava salkunhoitaja Jetro Siekkinen. ”Menestys on vahva osoitus aktiivisen salkunhoitomme tuloksellisuudesta, joka näkyy ennen kaikkea asiakkaidemme sijoitusten kehityksessä.”Morningstar on riippumaton sijoitusmarkkinoita ja...

 Aktias fonder får toppbetyg i Morningstars jämförelser och är i särklass jämfört med andra fondbolag i Finland. Genomsnittet för Aktias fonder var 4,20 stjärnor i augusti 2020 medan den näst bästa i jämförelsen hade i genomsnitt 3,77 stjärnor. I jämförelsen som baserar sig på Morningstars ratingar beaktas det fondandelsslag som fått flest stjärnor för varje fond.”Vi är mycket glada över att vårt fruktbara och långsiktiga arbete syns så här tydligt. I Morningstars jämförelser kan man vara framgångsrik endast om man har haft mycket goda långsiktiga resultat”, säger portföljförvaltare Jetro Siekkinen, som ansvarar för Aktias placeringsverksamhet. ”Framgången är ett starkt bevis på en resultatrik aktiv portföljförvaltning, vilket syns framför allt i utvecklingen av våra kunders placeringar.”Morningstar är en oberoende aktör som analyserar...

Aktia’s funds are at the top when comparing the Morningstar ratings for the funds of different fund management companies in Finland. The average rating for Aktia’s funds was 4.20 stars in August 2020, whereas the next best had an average of 3.77. The fund unit type of each fund that has received the most stars has been considered in the comparison based on Morningstar’s ratings.“We are very happy that our successful and persevering work can clearly be seen also in this comparison. It is only possible to be successful in Morningstar’s ratings if the results have been especially good in the long term”, says Jetro Siekkinen, portfolio manager in charge of Aktia’s asset management. “Our success is a strong token that our active portfolio management is profitable, which is above all reflected in the development of our customers’ investments.”Morningstar...

MENLO PARK, Calif. and BOSTON, Sept. 22, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, announced today that it has determined not to proceed with its proposed public offering of 4,500,000 shares of its common stock previously announced on September 21, 2020. The Company believes that current market conditions are not conducive to an offering on terms that would be in the best interests of its current stockholders. “We are well capitalized into 2022 and expect to meet multiple near-term milestones,” said Chen Schor, President and Chief Executive Officer of Adicet Bio, Inc. “Given our solid financial position and outlook, we look forward to advancing our gamma delta T cell platform and programs.”Adicet...

Tom Stepien, CEO & Co-founder of Primus Power, appointed to EMN’s Board of DirectorsAndrea Zaradic promoted to Vice President, OperationsThomas Glück appointed Chief Technology OfficerVANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (the “Company”) is pleased to announce that following a comprehensive search process, Mr. Tom Stepien has been appointed as a director of the Company, that Ms. Andrea Zaradic P.Eng., has joined the Company as Vice President, Operations, and that Dr. Thomas Glück has been appointed EMN’s Chief Technology Officer. All appointments are effective September 22, 2020.Tom Stepien has over 30 years of global high technology management, operations and engineering experience at small and large companies. He is currently CEO of Primus Power, a battery energy...

BRISBANE, Australia, Sept. 23, 2020 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (Orocobre or the Company), advises that its 2020 Annual General Meeting (AGM) will be held at 10.30am AEST on Friday 13 November 2020. In the interests of safety for shareholders, employees and the broader community during the COVID-19 pandemic, the 2020 AGM will be held virtually, rather than at a physical location.Shareholders will be provided with information on how to participate in the AGM when the Notice of Meeting is released in October 2020. The Notice of Meeting will also be available on the ASX Company Announcements Platform and Orocobre’s website at: https://www.orocobre.com.The closing time for receipt of director nominations for any candidates other than those recommended by the Board is 5.00pm AEST, Thursday 1 October 2020.This...

TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Funds (NEO:FGX), (NEO:FCS.UN), is pleased to announce the monthly distributions payable on the Shares and Trust Units of the below listed Funds.Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. and Faircourt Split Trust.This press release is not for distribution in the United States or over United States wire services.For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com or please contact 1-800-831-0304.You will usually pay brokerage fees to your dealer if you purchase or sell Units of the Trust on the NEO Exchange or other alternative Canadian trading system (an “exchange”). If the Units are purchased or sold on an exchange, investors may pay more than the...

LONDON and SINGAPORE, Sept. 22, 2020 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, today announced the appointment of Riad Chowdhury as Head of Asia Pacific, effective September 23, 2020.  Based in Singapore, Mr. Chowdhury will lead the growth strategy for MarketAxess’ expanding Asia Pacific business. He will report to Christophe Roupie, Head of EMEA and APAC. Mr. Chowdhury will be responsible for all business operations for MarketAxess in the region, including the active expansion of the firm’s relationships with regional and global institutional investors and dealers.Christophe Roupie, Head of EMEA and APAC at MarketAxess, said: “Riad brings...